Mette Kirstine Agger

Mette Kirstine Agger

DirectoratLexeo Therapeutics· In proxies 2023–2025

Mette Kirstine Agger sits on 4 public boards.

Boards1

  • Lexeo TherapeuticsDirector · 5 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Lexeo TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -69%
  2. Veloxis Pharmaceuticals APublic company
    • Director? – PresentNo stock prices for these years
  3. Imara Inc.Public company · 4 yr
    • Director2016 – 2020 · 4 yrNo stock prices for these years
  4. Trevi Therapeutics, Inc.Public company · 2 yr
    • Director2017 – 2019 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?